Richard Furie is a Rheumatology/Immunology physician affiliated with Northwell Health. OpenAlex indexes 392 publications with 25,246 citations (h-index 71); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2800 Marcus Ave
Suite 200
New Hyde Park, NY 110421008
Telephone
516-708-2550Registry record last updated 8 Jul 2007.
Clinical trials
- 3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
Sponsor: Northwell Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chugai Pharmaceutical Co., Ltd.Program year202511 payments$25,878openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202518 payments$24,831openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year202512 payments$23,537openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2010–2010 per NIH RePORTER. The latest:
- EFFECTS OF INDOLE-3-CARBINOL/DIM ON PATIENTS WITH LUPUS
Feinstein Institute for Medical Research
FY2010$3,392M01RR018535
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases
2023 - B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Annals of the Rheumatic Diseases
2022 - Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
Annals of the Rheumatic Diseases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Gregersen
Northwell Health
Louis Kavoussi, MD
Northwell Health
David Eidelberg, MD
Northwell Health
Francisco Esteva, MD, PhD
Northwell Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”